Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 1/20 | 0.53 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.53 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.53 |
| ▸ | NTSR1 | P30989 | 5/20 | 0.53 |
| ▸ | F2 | P00734 | 5/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.51 |
| ▸ | REN | P00797 | 1/20 | 0.51 |
| ▸ | NTSR2 | O95665 | 3/20 | 0.51 |
| ▸ | SORT1 | Q99523 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31226869 | 0.88 | NTSR1 (0.60) | NTSR1F2OPRD1NTSR2 | |
| SCHEMBL30567780 | 0.85 | F2 (0.60) | MAPK8MAPK9MAPK10F2 | |
| SCHEMBL29416782 | 0.84 | CALCR (0.62) | F2 | |
| SCHEMBL31462075 | 0.84 | CALCR (0.54) | MAPK8MAPK9MAPK10F2OPRD1 | |
| SCHEMBL30812505 | 0.83 | OPRD1 (0.60) | NTSR1OPRD1RENNTSR2SORT1 | |
| SCHEMBL28111222 | 0.83 | F2 (0.63) | NTSR1F2NTSR2SORT1 | |
| SCHEMBL28062744 | 0.83 | OPRD1 (0.58) | MAPK8MAPK9MAPK10NTSR1F2 | |
| SCHEMBL30389973 | 0.83 | OPRD1 (0.52) | NTSR1OPRD1REN | |
| SCHEMBL30504141 | 0.83 | NTSR1 (0.57) | NTSR1OPRD1NTSR2SORT1 | |
| SCHEMBL31462040 | 0.82 | CALCR (0.54) | F2OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3574909-B1 | POLYELECTROLYTE MULTILAYER COMPRISING SILVER FOR WOUND HEALING | IMBED BIOSCIENCES INC (US) | 2026-03-04 | — | — | EP | disclosed |
| US-20260000805-A1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | IMBED BIOSCIENCES INC (US) | 2026-01-01 | — | — | US | disclosed |
| US-12409247-B2 | Methods and compositions for wound healing | IMBED BIOSCIENCES INC. (US) | 2025-09-09 | — | — | US | disclosed |
| US-20240009342-A1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | IMBED BIOSCIENCES INC. | 2024-01-11 | — | — | US | disclosed |
| EP-4289910-A2 | METHODS AND COMPOSITIONS FOR WOUND HEALING | Imbed Biosciences, Inc. (US) | 2023-12-13 | — | — | EP | disclosed |
| EP-3490622-B1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | IMBED BIOSCIENCES INC (US) | 2023-09-06 | — | — | EP | disclosed |
| US-11554194-B2 | Methods and compositions for wound healing | IMBED BIOSCIENCES INC. (US) | 2023-01-17 | — | — | US | disclosed |
| EP-3995158-A1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | Imbed Biosciences, Inc. (US) | 2022-05-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260000805-A1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | PCNA, ARG1, PLOD3 | MAPK8 999/4885MAPK9 484/4885MAPK10 340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.